P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates-Reference-Cited by-同舟云学术

P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates

Published:2018 Issue:11 Volume:6 Page:3063-3074
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Mao Chengqiong¹²³⁴⁵^ORCID,Qu Ping¹²³⁴⁵,Miley Michael J.⁶⁷⁸⁵,Zhao Yan¹²³⁴⁵^ORCID,Li Zibo⁹⁷⁸⁵^ORCID,Ming Xin¹²³⁴⁵^ORCID

Affiliation:

1. Departments of Cancer Biology and Biomedical Engineering

2. Comprehensive Cancer Center

3. Wake Forest University School of Medicine

4. Winston Salem

5. USA

6. Department of Pharmacology

7. University of North Carolina at Chapel Hill

8. Chapel Hill

9. Department of Radiology and Biomedical Research Imaging Center

Abstract

The conjugates of recombinant antibody fragments were developed for Pgp-targeted PDT, providing a highly cancer-specific approach to combat chemoresistant tumors.

Funder

National Institutes of Health

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2018/BM/C8BM00844B

Reference39 articles.

1. Revisiting the role of ABC transporters in multidrug-resistant cancer

2. Targeting multidrug resistance in cancer

3. Multidrug resistance in cancer: role of ATP–dependent transporters

4. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

5. Where is it and How Does it Get There – Intracellular Localization and Traffic of P-glycoprotein

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photodynamic priming modulates cellular ATP levels to overcome P‐glycoprotein‐mediated drug efflux in chemoresistant triple‐negative breast cancer;Photochemistry and Photobiology;2024-06-02

2. Synergistic treatment of doxorubicin-resistant breast cancer by the combination of chemotherapy and photodynamic therapy;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2022-09

3. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer;International Journal of Pharmaceutics;2022-09

4. Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond;Theranostics;2022

5. Photoimmunotherapy: A New Paradigm in Solid Tumor Immunotherapy;Cancer Control;2022-01